The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Accord Healthcare; Acraf; Amgen Astellas BioPharma; AstraZeneca; Bayer Health; BMSi; Helsinn Healthcare; Ipsen; Johnson & Johnson; Lilly; Merck KGaA; MSD; Novartis; Roche; Sandoz; Sanofi; Tesaro
Speakers' Bureau - Abbvie; Accord Healthcare; Acraf; Amgen; Astellas Amgen BioPharama; AstraZeneca; Bayer; BMSi; Helsinn Healthcare; Ipsen; Johnson & Johnson; Lilly; Merck; MSD; Novartis; Roche; Sandoz; Sanofi; Tesaro
Research Funding - Abbvie; Accord Healthcare; Acraf; Amgen; Astellas Amgen BioPharama; AstraZeneca; Bayer; BMSi; Helsinn Healthcare; Ipsen; Johnson & Johnson; Lilly; Merck KGaA; MSD; Novartis; Roche; Sandoz; Sanofi; Tesaro
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting (CINV): Results of the Nausea/Emesis Registry in Oncology (NERO).
 
Matti S. Aapro
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb (Inst); Daiichi Sankyo; Fresenius Kabi; G1 Therapeutics; Genomic Health; Helsinn Healthcare; Merck; Merck KGaA; Novartis; Pfizer; Pierre Fabre; Roche (Inst); Sandoz; Tesaro; Vifor Pharma
Speakers' Bureau - Accord Research; Amgen; Biocon; Dr. Reddy's; Genomic Health; Helsinn Healthcare; Mundipharma; Novartis; Pfizer; Pierre Fabre; Roche; Sandoz; Taiho Pharmaceutical; Tesaro; Vifor Pharma
Research Funding - Helsinn Healthcare (Inst); Novartis (Inst); Pierre Fabre (Inst); Sandoz
 
Marika Chrápavá
No Relationships to Disclose
 
Razvan-Ovidiu D. Curca
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Roche
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Bayer; Ipsen; Johnson & Johnson; Lilly; Merck KGaA; Novartis; Roche; Sandoz; Sanofi
Research Funding - Abbvie; Acraf; AstraZeneca; AstraZeneca (Inst); Merck KGaA; Merck KGaA (Inst); Roche/Genentech; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; SERVIER
 
Laurentia Gales
No Relationships to Disclose
 
Alexandru Calim Grigorescu
No Relationships to Disclose
 
Bára Karlínová
No Relationships to Disclose
 
Renata Kellnerová
Employment - Acraf
 
Edgar Petru
No Relationships to Disclose
 
Adam Pluzanski
No Relationships to Disclose
 
Maryna Rubach
Consulting or Advisory Role - Acraf
Travel, Accommodations, Expenses - Acraf
 
Guenther G. Steger
Consulting or Advisory Role - Amgen; Novartis; Roche; Teva
Travel, Accommodations, Expenses - Amgen; Novartis; Roche; Teva
 
Petra Tesarova
No Relationships to Disclose
 
Nicolay Yordanov
No Relationships to Disclose
 
Anna Walaszkowska-Czyz
No Relationships to Disclose